Efavirenz Therapeutic Range in HIV-1 Treatment Naïve Participants

OBJECTIVES: Efavirenz is currently suggested as an alternative to recommended antiretroviral (ARV) regimens by the Department of Health and Human Services for the treatment of HIV-1 in ARV-naive patients. A mid-dosing interval therapeutic range between 1,000 and 4,000 ng/mL for efavirenz has been pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ther Drug Monit
Hauptverfasser: Bednasz, Cindy J., Venuto, Charles S., Ma, Qing, Daar, Eric S., Sax, Paul E., Fischl, Margaret A., Collier, Ann C., Smith, Kimberly Y., Tierney, Camlin, Yang, Yang, Wilding, Gregory E., Morse, Gene D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5718358/
https://ncbi.nlm.nih.gov/pubmed/29135907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0000000000000443
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge